December 2023
Newsletter: TBE vaccines can induce antibodies to non-structural protein 1 (NS-1)
Snapshot 51/2023 TBE in dogs, Lithuania
November 2023
Snapshot 47/2023 Emergency department syndromic surveillance to monitor tick-borne diseases
Snapshot 46/2023 Prevalence of TBE antibodies in wild ungulates in northern Italy
Snapshot 45/2023 Protection of Langat virus antibodies against lethal TBE virus infection in mice
Snapshot 44/2023 TBE in a horse, Austria
October 2023
Newsletter: History of TBE and TBE vaccine development
Snapshot 42/2023 Ixodes persulcatus in Sweden and Finland
Snapshot 41/2023 Development of a TBE vaccine to protect dogs
Snapshot 40/2023 TBE in Croatia
September 2023
Newsletter: Effectiveness of TBE vaccines in children, Latvia
Snapshot 39/2023 Analyzing biomarkers of prognostic value for severity of TBE
Snapshot 37/2023 Multiple functions of the non-structural protein 1 of flaviviruses
Snapshot 36/2023 TBE in Mongolia
August 2023
Newsletter: Effectiveness of TBE vaccination in Latvia
Snapshot 34/2023 Origin of the Baikal subtype of TBE virus
Snapshot 33/2023 Testing nucleoside/nucleotide analogs against TBE virus and West Nile virus
Snapshot 32/2023 Assessing ribavirin as an anti-TBE virus drug
July 2023
Snapshot 30/2023 Virus-like particle-based vaccine to protect against TBE virus infection
Snapshot 27/2022 Analyzing the increase of TBE incidence in Scandinavia
June 2023
Snapshot 26/2023 Analyzing two TBE vaccine failures: was antibody mismatch the cause?
Snapshot 25/2023 Knowledge, attitudes and behaviors among physicians regarding TBE in southern
Snapshot 24/2023 Testing accelerated TBE vaccination schedules for last-minute travelers
Snapshot 23/2023 Long-lasting TBE antibody persistence after vaccination
May 2023
Snapshot 22/2023 Horses as sentinels for flavivirus infection
Snapshot 21/2023 Analyses of ticks and humans bitten by ticks for TBE and borreliosis
Snapshot 19/2023 Fourth case of TBE in the United Kingdom
Snapshot 18/2023 Underdiagnosis of TBE in Germany
April 2023
Newsletter: Acute clinical manifestations of TBE
Snapshot 17/2023 TBE in the EU/EEA, 2012–2020
Snapshot 16/2023 TBE seropositivity of sheep in southern Germany
Snapshot 15/2023 TBE vaccine field effectiveness against severe and mild forms of disease
Snapshot 14/2023 Seroprotection rates vs. vaccination rates in southern Germany
March 2023
Newsletter: TBE cases in Central Europe, 2022
Snapshot 13/2023 Concomitant application of flavivirus vaccines
Snapshot 12/2023 Cross-reactivity among sera from various flaviviruses
Snapshot 11/2023 Immunization status in patients with multiple sclerosis, Austria
Snapshot 10/2023 Severe TBE virus infection of a pregnant woman
February 2023
Snapshot 9/2023 TBE seroprevalence in mice from natural TBE foci
Snapshot 8/2023 TBE and TBE vaccination in Hungary
Snapshot 7/2023 Spanish goat encephalitis virus: a significant pathogen of goats
Snapshot 6/2023 Low TBE vaccination rate among German soldiers
January 2023
Snapshot 5/2023 TBE and other flaviviruses in the Chelyabinsk region, Russia
Snapshot 4/2023 Strong increase in new TBE foci in southern Germany
Snapshot 3/2023 TBE vaccine coverage in Switzerland
Snapshot 2/2023 The search for drugs to treat TBEvirus
Snapshot 1/2023 Fatal TBE case in a Serbian tourist